Noom Launches Free Version of Its Powerful GLP-1 Companion Empowering Providers with a Research-Backed Tool to Support Weight Loss That Lasts Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for good PRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider
Cigna offers employers a range of benefit package options, including some that incorporate anti-obesity medication coverage
Payment method fees
This category covers the secretagogues which act on the GHRH and ghrelin receptor axes alongside the repair-oriented peptides most often paired with them in laboratory work
Although the absolute risk of clinically recorded alopecia associated with GLP-1 receptor agonist use is low, the observed association may still influence patients satisfaction, adherence, and decisions to start or continue therapy, Yong Chen, PhD, of the University of Pennsylvanias Perelman School of Medicine, wrote
